Immunogenetics: A Molecular and Clinical Overview, Vol. 3: Immune Cells and Immunotherapeutics in Recurrent Miscarriage

Texte du rabat

Immunogenetics: A Molecular and Clinical Overview, Vol. 3, Immune Cells and Immunotherapeutics in Recurrent Miscarriage provides an overview of the scientific knowledge, achievements, and findings in the field of immunogenetics of recurrent pregnancy loss. With a strong focus on the role immune cells can play in recurrent pregnancy loss, the book also examines immune therapeutic aspects. In fifteen chapters, the book describes the roles of both helper cells, nature killer cells, lymphoid cells, regulatory cells and macrophages in recurrent pregnancy loss. In addition, it describes clinical outcomes of several therapies and gives insight into new treatments. This new release is a valuable resource for health professionals, scientists and researchers, and all those who wish to broaden their knowledge in the allied field.

Contenu

1. Role of CD4+ T helper cells (Th1, Th2 and Th17 cells) in Recurrent pregnancy loss2. Role of Nature Killer and Innate lymphoid cells in Recurrent pregnancy loss3. Role of T Regulatory in Recurrent pregnancy loss4. Role of CD8+ Cytotoxic T cells in Recurrent pregnancy loss5. Role of B cells, macrophages and dendritic cells in Recurrent pregnancy loss6. Clinical outcome of Low molecular weight heparin and aspirin therapy in Recurrent pregnancy loss patients7. Clinical outcome of Intravenous immunoglobulin (IVIg) therapy in Recurrent pregnancy loss patients8. Vitamin D3 therapy and clinical outcome in Recurrent pregnancy loss patients9. Efficacy of Intralipid infusion therapy in the treatment of Recurrent pregnancy loss patients 10. Therapeutic potential of Cyclosporine A in Recurrent pregnancy loss11. Progesterone therapy and clinical outcome in Recurrent pregnancy loss patients12. Granulocyte-Colony Stimulating Factor (G-CSF) therapy in Recurrent pregnancy loss patients13. Lymphocyte immunotherapy (LIT) and clinical outcome in Recurrent pregnancy loss patients14. TNFa inhibition and treatment of Recurrent pregnancy loss15. Genetic counselling and clinical pregnancy outcome16. Importance of evidence-based medical treatments for Recurrent pregnancy loss17. Evidence-based new developments in reproductive immunogenetics and future perspectives